Keivan Majidzadeh-A
Overview
Explore the profile of Keivan Majidzadeh-A including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zandieh A, Shariatpanahi S, Ravassipour A, Azadipour J, Nezamtaheri M, Habibi-Kelishomi Z, et al.
Sci Rep
. 2025 Jan;
15(1):2964.
PMID: 39849096
Observing quantum mechanical characteristics in biological processes is a surprising and important discovery. One example, which is gaining more experimental evidence and practical applications, is the effect of weak magnetic...
2.
Sina M, Zarinfam S, Giliani S, Poliani P, Majidzadeh-A K
Eur J Cancer Prev
. 2024 Oct;
PMID: 39436407
Lynch syndrome accounts for 3-5% of all colorectal and endometrial cancer cases, and suboptimal management of Lynch syndrome in the Middle East resulted in the underdiagnosis of mutation carriers. Probands...
3.
Yadegari F, Abed A, Abd Ali W, Al-Abedi H, Zarinfam S, Aminian S, et al.
Clin Case Rep
. 2024 Jul;
12(8):e9176.
PMID: 39055085
This study presents a family with nine children, two of them diagnosed with RTS2 using genetic testing. The other siblings show some of the RTS2 criteria and are suggestive of...
4.
Aminian S, Al-Alloosh F, Yadegari F, Zarinfam S, Al-Abedi H, Majidzadeh-A K
Case Rep Genet
. 2024 Jun;
2024:5591237.
PMID: 38873645
Multiple primary cancers (MPCs) are defined as the presence of more than one cancer in an individual that is not due to recurrence, metastasis, or local spread. Different factors such...
5.
Yadegari F, Farahmand L, Esmaeili R, Zarinfam S, Majidzadeh-A K
J Biomol Struct Dyn
. 2023 Nov;
42(11):5734-5746.
PMID: 37948190
Pathogenic mutations in are associated with an increased risk of hereditary breast, ovarian, and some other cancers; however, the clinical significance of many mutations in this gene remains unknown (Variants...
6.
Godau B, Samimi S, Seyfoori A, Samiei E, Khani T, Naserzadeh P, et al.
Pharmaceutics
. 2023 Sep;
15(9).
PMID: 37765224
Systemically administered chemotherapy reduces the efficiency of the anticancer agent at the target tumor tissue and results in distributed drug to non-target organs, inducing negative side effects commonly associated with...
7.
Arabpour M, Layeghi S, Majidzadeh-A K, Tavakkoly Bazzaz J, Mamivand A, Naghizadeh M, et al.
Biochem Biophys Rep
. 2023 Sep;
35:101531.
PMID: 37654678
Background: Luminal A and B subtypes of breast cancer (BC) comprises up to 70% of all BC patients. LncRNAs can affect many biological and pathological processes, and dysregulation of them...
8.
Ahmadvand M, Shokrollahi Barough M, Hashemi Z, Sanati H, Abbasvandi F, Yunesian M, et al.
Pilot Feasibility Stud
. 2023 Aug;
9(1):137.
PMID: 37542307
Background: NK cells are the most active innate immune cells in antiviral immunity, which are impaired by SARS-COV2 infection. Infusion of allogeneic NK cells might be a complementary treatment to...
9.
Hosseinjani-Pirdehi H, Amigh S, Mohajeri A, Nazeri E, Taheri A, Majidzadeh-A K, et al.
RSC Adv
. 2023 Mar;
13(15):9811-9823.
PMID: 36994144
In the present study, fluorogenic coumarin-based probes (1-3) through condensation of 4-hydroxy coumarin with malondialdehyde bis(diethyl acetal)/triethyl orthoformate were prepared. The absorption and fluorescence emission properties of 2b and 3...
10.
Rahmanian M, Sartipzadeh Hematabad O, Askari E, Shokati F, Bakhshi A, Moghadam S, et al.
J Adv Res
. 2022 Aug;
47:105-121.
PMID: 35964874
Introduction: The information derived from the number and characteristics of circulating tumor cells (CTCs), is crucial to ensure appropriate cancer treatment monitoring. Currently, diverse microfluidic platforms have been developed for...